A clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase, has been conducted. However, reports on the topic appear to be mixed up with unrelated medical studies. It is unclear what the results of the evaluation are, as the available information seems to pertain to various other medical topics.